Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 2
1995 5
1996 10
1997 11
1998 7
1999 19
2000 22
2001 26
2002 28
2003 23
2004 23
2005 30
2006 32
2007 30
2008 43
2009 44
2010 42
2011 39
2012 55
2013 60
2014 54
2015 65
2016 72
2017 69
2018 79
2019 87
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

899 results
Results by year
Filters applied: . Clear all
Page 1
SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy.
Veillette A, Chen J. Veillette A, et al. Trends Immunol. 2018 Mar;39(3):173-184. doi: 10.1016/j.it.2017.12.005. Epub 2018 Jan 11. Trends Immunol. 2018. PMID: 29336991 Review.
Cancer immunotherapy targeting the CD47/SIRPα axis.
Weiskopf K. Weiskopf K. Eur J Cancer. 2017 May;76:100-109. doi: 10.1016/j.ejca.2017.02.013. Epub 2017 Mar 10. Eur J Cancer. 2017. PMID: 28286286 Review.
MYC regulates the antitumor immune response through CD47 and PD-L1.
Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, Gouw AM, Baylot V, Gütgemann I, Eilers M, Felsher DW. Casey SC, et al. Science. 2016 Apr 8;352(6282):227-31. doi: 10.1126/science.aac9935. Epub 2016 Mar 10. Science. 2016. PMID: 26966191 Free PMC article.
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.
Kojima Y, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, Direnzo D, Nanda V, Ye J, Connolly AJ, Schadt EE, Quertermous T, Betancur P, Maegdefessel L, Matic LP, Hedin U, Weissman IL, Leeper NJ. Kojima Y, et al. Nature. 2016 Aug 4;536(7614):86-90. doi: 10.1038/nature18935. Epub 2016 Jul 20. Nature. 2016. PMID: 27437576 Free PMC article.
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer.
Weiskopf K, Jahchan NS, Schnorr PJ, Cristea S, Ring AM, Maute RL, Volkmer AK, Volkmer JP, Liu J, Lim JS, Yang D, Seitz G, Nguyen T, Wu D, Jude K, Guerston H, Barkal A, Trapani F, George J, Poirier JT, Gardner EE, Miles LA, de Stanchina E, Lofgren SM, Vogel H, Winslow MM, Dive C, Thomas RK, Rudin CM, van de Rijn M, Majeti R, Garcia KC, Weissman IL, Sage J. Weiskopf K, et al. J Clin Invest. 2016 Jul 1;126(7):2610-20. doi: 10.1172/JCI81603. Epub 2016 Jun 13. J Clin Invest. 2016. PMID: 27294525 Free PMC article.
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors.
Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier WA, Xu H, Peng H, Fu YX, Xu MM. Liu X, et al. Nat Med. 2015 Oct;21(10):1209-15. doi: 10.1038/nm.3931. Epub 2015 Aug 31. Nat Med. 2015. PMID: 26322579 Free PMC article.
Is CD47 an innate immune checkpoint for tumor evasion?
Liu X, Kwon H, Li Z, Fu YX. Liu X, et al. J Hematol Oncol. 2017 Jan 11;10(1):12. doi: 10.1186/s13045-016-0381-z. J Hematol Oncol. 2017. PMID: 28077173 Free PMC article. Review.
899 results
Jump to page
Feedback